The medical sharps market is forecast to expand from USD 10.95 billion in 2026 to USD 19.79 billion by 2036, registering a 6.1% CAGR over the forecast period. Fact.MR attributes this growth to increasing healthcare utilization, expanding immunization programs, and the continued need for disposable instruments across medical procedures. Rising demand for injectable therapies, blood collection, diagnostics, and chronic disease management is also supporting the market's development.

Medical sharps remain essential across hospitals, diagnostic laboratories, outpatient facilities, and home healthcare settings. Needles, syringes, lancets, and surgical instruments support routine treatment and diagnostic procedures. Growing attention to occupational safety is encouraging healthcare providers to adopt safety-engineered devices that help reduce needlestick injuries. At the same time, increasing demand for injectable medications and the expansion of healthcare infrastructure are creating opportunities for manufacturers to develop reliable and cost-effective products.

Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.factmr.com/connectus/sample?flag=S&rep_id=13473

Hypodermic Needles Retain Leading Position

By product, hypodermic needles are expected to account for 28.0% of the medical sharps market in 2026. Their leading position reflects their widespread use in administering medications, vaccines, and other injectable fluids. These instruments are used across hospitals, clinics, and home healthcare environments, making them a fundamental component of modern treatment and diagnostic procedures. Continued improvements in needle gauge, length, and tip design are supporting efforts to improve patient comfort and reduce tissue trauma.

Drug delivery and injections represent the largest application segment, projected to capture 36.0% of the market in 2026. Injectable medicines are used across multiple therapeutic areas, including the administration of antibiotics, biologics, chemotherapy, and anesthesia. The need for dependable instruments for routine and specialized treatment continues to sustain demand. Growth in pharmaceutical utilization and chronic disease management is further supporting this application segment.

Hospitals remain the leading end-user category, accounting for 38.0% of the medical sharps market in 2026. Their position reflects the high volume and variety of procedures performed in hospital settings. These facilities require medical sharps for injections, blood collection, surgical interventions, and other clinical activities. Diagnostic laboratories, ambulatory surgical centers, and home healthcare services also contribute to demand as healthcare delivery expands across different care settings.

India, China, and Brazil Show Strong Growth Potential

India is projected to record an 8.5% CAGR from 2026 to 2036, making it the fastest-growing country among those highlighted in the report. Demand is supported by the country's expanding hospital and diagnostic infrastructure, the burden of diseases requiring injectable treatment, and large-scale immunization and public health programs. Greater access to healthcare services is creating additional requirements for needles, syringes, and other disposable medical instruments.

China is expected to advance at an 8.2% CAGR through 2036. Its market expansion reflects growing domestic healthcare requirements and its established medical device manufacturing base. Increasing procedural volumes are supporting demand for medical sharps, while the market is gradually moving beyond cost-focused products toward greater adoption of branded and safety-engineered devices. Domestic production capabilities also position China as an important supplier within the global medical device industry.

Brazil is projected to register a 7.6% CAGR during the forecast period. Its national public health system, known as SUS, supports widespread access to healthcare and large-scale immunization campaigns. Government procurement for public health programs, alongside the expansion of private hospitals and diagnostic centers, is contributing to demand. Requirements range from basic medical instruments used in primary care to safety-focused products used in more specialized clinical environments.

The USA is expected to record a 7.4% CAGR through 2036. Demand is supported by safety requirements, established healthcare infrastructure, and purchasing arrangements involving large group purchasing organizations. The country's market also benefits from demand across hospitals, outpatient facilities, and home healthcare. Safety-engineered products and improvements in device usability remain important considerations for healthcare providers.

Competitive Landscape

Competition in the medical sharps market includes manufacturers with established medical device portfolios, distribution networks, and product development capabilities. Key companies profiled by Fact.MR include BD (Becton, Dickinson and Company), Terumo Corporation, B. Braun Melsungen, Nipro Corporation, and Smiths Medical.

Purchasing decisions are influenced by product reliability, safety performance, cost, and suitability for clinical procedures. Healthcare providers must balance procurement costs with the need to reduce needlestick injuries and maintain dependable supplies. Manufacturers are therefore competing through product design, safety features, manufacturing capabilities, and distribution support across healthcare markets.

Technology and Safety Developments Shape the Market

Medical sharps manufacturers are placing greater emphasis on safety-engineered designs that help prevent needlestick injuries. Improvements in needle geometry, device ergonomics, and protective mechanisms are relevant as healthcare providers seek to strengthen workplace safety. The need to balance clinical performance with affordability remains important, particularly in markets where public health programs procure large volumes of disposable medical instruments.

The market is also being influenced by the growing use of biologics and high-viscosity injectable medications, which can create additional requirements for needle and delivery-system design. Fact.MR identifies material innovation, recyclability, and medical sharps waste-disposal regulations as further areas of interest. These developments are expected to influence product selection, manufacturing strategies, and waste-management practices across the healthcare supply chain.

As healthcare utilization and injectable treatment requirements continue to expand, medical sharps are expected to remain essential to clinical delivery through 2036. The full Fact.MR report provides detailed forecasts, product and application analysis, country-level growth estimates, and competitive assessments.

Top Reports:

https://adamaamresearch.blogspot.com/2026/10/non-medical-grade-aesthetic-devices.html

https://zeuspage.org/blogs/69922/Non-Medical-Grade-Aesthetic-Devices-Market-Worth-USD-17-3

https://kaamkaaziclub.com/read-blog/69218

https://net-pals.com/blogs/48648/Non-Medical-Grade-Aesthetic-Devices-Market-Set-to-Hit-USD

About Fact.MR

Fact.MR is a market research and consulting company providing market intelligence, competitive analysis, and forecasting across global industries. Its research supports businesses with data-driven insights into emerging markets, technology trends, competitive dynamics, regional opportunities, and changing demand patterns.